The incidence of metabolic disorders, including diabetes, has elevated exponentially during
the last decades and enhanced the risk of a variety of complications, such as diabetes and …

Inflammatory bowel disease (IBD) is a chronic systemic inflammatory condition. Previously,
the focus has been on extraintestinal manifestations of IBD, including arthritis, psoriasis, and …

Background Non-alcoholic fatty liver disease (NAFLD) is increasingly common in the adult
population. In the United States, the overall burden of NAFLD is unknown due to challenges …

Background and aim Flavonoids are natural products of plant origin and have been shown
to be beneficial for nonalcoholic fatty liver disease (NAFLD) in animal studies. However …

Abstract Background & Aims Malnutrition with the accumulation of fat tissue and
nonalcoholic fatty liver disease (NAFLD) are conditions associated with inflammatory bowel …

Helicobacter pylori (H. pylori) is a gram-negative bacterium that infects approximately 4.4
billion individuals worldwide. However, its prevalence varies among different geographic …

Background Non‐alcoholic fatty liver disease (NAFLD) is found in inflammatory bowel
disease (IBD). However, uncertainties remain on the magnitude of the association. Aims To …

BACKGROUND Nonalcoholic fatty liver disease (NAFLD) is a frequently reported condition
in patients with inflammatory bowel disease (IBD). Both intestinal inflammation and …

Background and Objectives: Inflammatory bowel disease (IBD) is a condition characterized
by chronic intestinal inflammation. We can identify two major forms: Crohn's disease (CD) …

Background Nonalcoholic fatty liver disease (NAFLD) is increasingly identified in patients
with inflammatory bowel disease (IBD), but there are few systematic reviews and meta …